期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Polymorphism of CYPIAl and GSTMl genes associated with susceptibility of gastric cancer in Shandong Province of China 被引量:9
1
作者 Hao li Xue-liang Chen hui-qing li 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第37期5757-5762,共6页
AIM: To explore whether polymorphisms of the CYPIA1 and GSTM1 genes are associated with susceptibility of stomach cancer. METHODS: A total of 102 stomach cancer cases and 62 healthy persons were diagnosed by patholo... AIM: To explore whether polymorphisms of the CYPIA1 and GSTM1 genes are associated with susceptibility of stomach cancer. METHODS: A total of 102 stomach cancer cases and 62 healthy persons were diagnosed by pathology in 1998- 2000 in the Qilu Hospital of Shandong University. Gene polymorphisms were detected by the PCR using sequencespecific primers. Data analysis of the case-control study was carried out using the unconditional logistic method. RESULTS: After adjustment for age, sex, educational levels, and occupation, the risk factors for stomach cancer were shown to be smoking, Helicobacter pylori (H pylon), and presence of the CYPIM G/G and GSTM1O/O genotypes. Interaction was observed between the combined genotypes of either CYPIA1 G/G and GSTM1O/O or Hpyloriinfection, or GSTM1O/O and Hpyloriinfection or smoking. CONCLUSION: Polymorphisms of the CYPIA1 and GSTM1 genes, Hpyloriinfection and smoking are related to susceptibility to stomach cancer. 展开更多
关键词 Stomach cancer CYPIA1 GSTM1 POLYMORPHISM
下载PDF
Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases 被引量:2
2
作者 Yong GAO Hai-bo QIU +27 位作者 Shu ZHOU Zhen-ning WANG Jian-chu ZHANG Zheng-liang ZHANG Zhao-xin QIAN Hong-bo WANG Shi-huan YU Yi-feng LUO Ya dan WANG Zhuang liU Wei-ci WANG Ming JIA li-ming ZHANG Yu ZHANG Yang JIN Yong ZHANG Yong liU Zi-hua ZHOU Ying SU hui-qing li Wei-min XIAO Kai HUANG Ping HE Gang li Zhao-hui FU Shi liU Neng xing liN Fan-jun CHENG 《Current Medical Science》 SCIE CAS 2020年第4期597-601,共5页
Summary:In late December 2019,COVID-19 was firstly recognized in Wuhan,China and spread rapidly to all of the provinces of China.The West Campus of Wuhan Union Hospital,the designated hospital to admit and treat the s... Summary:In late December 2019,COVID-19 was firstly recognized in Wuhan,China and spread rapidly to all of the provinces of China.The West Campus of Wuhan Union Hospital,the designated hospital to admit and treat the severe and critically ill COVID-19 cases,has treated a large number of such patients with great success and obtained lots of valuable experiences based on the Chinese guideline(V7.0).To standardize and share the treatment procedures of severe and critically ill cases,Wuhan Union Hospital has established a working group and formulated an operational recommendation,including the monitoring,early warning indicators,and several treatment principles for severe and critically ill cases.The treatment experiences may provide some constructive suggestions for treating the severe and critically ill COVID-19 cases all over the world. 展开更多
关键词 2019-nCoV COVID-19 PNEUMONIA TREATMENT GUIDELINES
下载PDF
直接多肽反应在预测注射用曲克芦丁过敏反应中的应用
3
作者 张琪 于德志 +2 位作者 李会轻 高倩 杨钊 《药物流行病学杂志》 CAS 2023年第9期1041-1047,共7页
目的建立直接多肽反应试验(DPRA)的致敏检测方法,对发生药品不良反应(ADR)聚集性信号的注射用曲克芦丁的致敏性进行评价。方法运用HPLC法,测定注射用曲克芦丁涉ADR批次和正常批次对半胱氨酸多肽(Cys)和赖氨酸多肽(Lys)的消耗量。结果涉... 目的建立直接多肽反应试验(DPRA)的致敏检测方法,对发生药品不良反应(ADR)聚集性信号的注射用曲克芦丁的致敏性进行评价。方法运用HPLC法,测定注射用曲克芦丁涉ADR批次和正常批次对半胱氨酸多肽(Cys)和赖氨酸多肽(Lys)的消耗量。结果涉ADR批次及正常批次制剂,与Cys和Lys均不发生共洗脱,采用1∶10 Cys和1∶50 Lys模型预测,各批次之间的数据结果差异较小,依模型预测判定各批次致敏性均为阴性。结论各批次注射用曲克芦丁DPRA方法预测结果均为阴性,基于该方法原理分析,初步判定涉ADR批次注射用曲克芦丁发生临床ADR聚集性信号原因应与小分子半抗原无关,同时探讨了该方法用于预测致敏成分是否为小分子半抗原的可行性。 展开更多
关键词 注射用曲克芦丁 药品不良反应 直接多肽反应试验 过敏反应 半抗原
下载PDF
Association of Interleukin-6-174G/C Polymorphism with the Risk of Diabetic Nephropathy in Type 2 Diabetes:A Meta-analysis 被引量:6
4
作者 Zhen-hai CUI Xiao-ting LU +2 位作者 Kang-li XIAO Yang CHEN hui-qing li 《Current Medical Science》 SCIE CAS 2019年第2期250-258,共9页
Previous studies reported the association between interleukin-6(IL-6)-174G/C gene polymorphism and the risk of diabetic nephropathy in type 2 diabetes mellitus(T2DN).However,the results remain controversial.In the pre... Previous studies reported the association between interleukin-6(IL-6)-174G/C gene polymorphism and the risk of diabetic nephropathy in type 2 diabetes mellitus(T2DN).However,the results remain controversial.In the present study,we conducted a meta-analysis to further examine this relationship between IL-6-174G/C gene polymorphism and T2DN.Three databases(PubMed,SinoMed and ISI Web of Science)were used to search clinical case-control studies about IL-6-174G/C polymorphism and T2DN published until Apr.14,2018.Fixed-or random-effects n lodels were used to calculate the effect sizes of odds ratio(OR)and 95%confide nee intervals(95%CI).Moreover,subgroup analysis was performed in tenns of the excretion rate of albuminuria.All the statistical analyses were con ducted using Stata 12.0.A total of 11 case-control studies were included in this study,involving 1203 cases of T2DN and 1571 cases of T2DM without DN.Metaanalysis showed that there was an association between IL-6-174G/C polymorphism and increased risk of T2DN under the allelic and recessive genetic models(G vs.C:OR=1.10,95%CI 1.03-1」&P=0.006;GG vs.CC+GC:OR=1.11,95%CI 1.02-1.21,P=0.016).In the subgroup analysis by albuminuria,a significant association of IL-6-174G/C polymorphism with risk of T2DN was noted in the microalbuminuria group under the recessive model(OR=1.54,95%CI 1.02-2.32,P=0.038).In conclusion,this meta-analysis suggests that IL-6-174G/C gene polymorphism is associated with the risk of T2DN. 展开更多
关键词 interleukin-6(IL-6)-174G/C gene POLYMORPHISM DIABETIC NEPHROPATHY type 2 diabetes MELLITUS META-ANALYSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部